PDCD1 and neoplasm: The human anti-CTLA4 antibody binds to CTLA4 on the T-cell surface, blocking CTLA4 from shutting down T-cell activation in the early stage, whereas the human anti-PD1 antibody binds to PD1, preventing tumor cells from inhibiting T-cell activity (Fig. 4a).